CBA:ASXCommonwealth Bank of Australia Analysis
Data as of 2026-06-12 - not real-time
A$159.26
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
CBA shares are trading around $159, below the 20‑day (≈$162) and 50‑day (≈$170) moving averages, with a bearish MACD histogram and a neutral RSI near 40, indicating limited upside momentum. The stock exhibits a high 30‑day volatility of roughly 38% while its beta is low at about 0.26, suggesting price swings are driven more by company‑specific factors than market moves. Valuation metrics are stretched, as the trailing P/E of 25.6 far exceeds the industry average of 16.6, and the price‑to‑book sits above 3.4, reinforcing an overvalued view. Despite a dividend yield of 3.16% and a payout ratio near 78%, operating cash flow is negative and free cash flow is nil, raising questions about the dividend’s durability. Analyst consensus leans toward a “sell” rating, and recent headlines are split, with some commentators flagging CBA as a sell candidate while others note it as a potential buy among blue‑chip stocks.
Overall, the combination of elevated valuation, weak cash generation, and mixed sentiment suggests caution. The high dividend is attractive but may not be sustainable, and the stock’s technical profile points to further downside pressure in the short term. Medium‑term prospects remain uncertain, hinging on whether earnings growth can justify the premium and if cash flow improves. Long‑term investors should monitor regulatory developments and the bank’s ability to stabilize earnings before committing additional capital.
Overall, the combination of elevated valuation, weak cash generation, and mixed sentiment suggests caution. The high dividend is attractive but may not be sustainable, and the stock’s technical profile points to further downside pressure in the short term. Medium‑term prospects remain uncertain, hinging on whether earnings growth can justify the premium and if cash flow improves. Long‑term investors should monitor regulatory developments and the bank’s ability to stabilize earnings before committing additional capital.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below key moving averages
- Bearish MACD signal
- Analyst consensus rating of sell
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Overvalued multiples relative to peers
- Attractive dividend yield but cash flow concerns
- Sector stability offset by regulatory headwinds
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential for earnings growth to justify valuation
- Dividend attractiveness if cash generation improves
- Long‑term market position as Australia’s largest bank
Key Metrics & Analysis
Financial Health
Revenue Growth6.60%
Profit Margin36.35%
P/E Ratio25.6
ROE13.64%
ROA0.77%
P/B Ratio3.4
Op. Cash FlowA$-45702000640
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI40.6
SupportA$156.42
ResistanceA$166.31
MA 20A$162.38
MA 50A$170.10
MA 200A$166.01
MACDBearish
VolumeIncreasing
Fear & Greed Index86.71
Valuation
Target PriceA$122.78
Upside/Downside-22.91%
GradeOvervalued
TypeBlend
Dividend Yield3.16%
Risk Assessment
Beta0.26
Volatility38.51%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.